Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) Fails to deliver data
Key failure to deliver metrics for Curis:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $1.02 M
Failures to deliver for Curis (CRIS) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Curis (CRIS) - since 2018
Volume in USD (price x number of shares), data since 2018Curis (CRIS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $1.13 M | -50.11% |
| 2022 | $2.28 M | -83.08% |
| 2021 | $13.49 M | -24.34% |
| 2020 | $17.83 M | 1450.87% |
| 2019 | $1.14 M | -30.13% |
| 2018 | $1.64 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | N/A | $0.44 M | 🇺🇸 USA |
 Exelixis EXEL | $0.65 M | $6.15 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.8 M | $3.83 M | 🇺🇸 USA |
 Cel-Sci
CVM | $0.55 M | $5.02 M | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.74 M | $6.58 M | 🇺🇸 USA |